• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The value of reporting therapeutic ineffectiveness as an adverse drug reaction.

作者信息

Meyboom R H, Lindquist M, Flygare A K, Biriell C, Edwards I R

机构信息

The Uppsala Monitoring Centre, WHO Programme for International Drug Monitoring, Uppsala, Sweden.

出版信息

Drug Saf. 2000 Aug;23(2):95-9. doi: 10.2165/00002018-200023020-00001.

DOI:10.2165/00002018-200023020-00001
PMID:10945372
Abstract

Therapeutic ineffectiveness is a frequent drug-related problem that can occur in a variety of different situations and be caused by different mechanisms. Examples are inappropriate use, interactions or metabolic abnormalities. Observations in patients of unexpected ineffectiveness can provide important information with regard to such situations. Therefore, ineffectiveness--especially when unexpected or unexplained--is a potentially important reportable event in pharmacovigilance. The terms regarding ineffectiveness in the WHO Adverse Reaction Terminology (WHOART) have been recently revised in order to enable optimal coding of such case reports.

摘要

相似文献

1
The value of reporting therapeutic ineffectiveness as an adverse drug reaction.
Drug Saf. 2000 Aug;23(2):95-9. doi: 10.2165/00002018-200023020-00001.
2
Therapeutic ineffectiveness: heads or tails?治疗无效:正面还是反面?
Drug Saf. 2002;25(7):485-7. doi: 10.2165/00002018-200225070-00002.
3
Characteristics and trends of spontaneous reporting of therapeutic ineffectiveness in South Korea from 2000 to 2016.2000 年至 2016 年韩国治疗无效自发报告的特征和趋势。
PLoS One. 2019 Feb 28;14(2):e0212905. doi: 10.1371/journal.pone.0212905. eCollection 2019.
4
Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.利用美国食品药品监督管理局(FDA)上市后自发报告数据挖掘药物相互作用的关联模式。
J Biomed Inform. 2016 Apr;60:294-308. doi: 10.1016/j.jbi.2016.02.009. Epub 2016 Feb 20.
5
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
6
[Application analysis of adverse drug reaction terminology WHOART and MedDRA].[世界卫生组织药品不良反应术语集(WHOART)与医学术语词典(MedDRA)的应用分析]
Zhongguo Zhong Yao Za Zhi. 2015 Dec;40(24):4728-33.
7
Adverse drug reactions in neonates: could we be documenting more?新生儿的药物不良反应:我们是否能记录得更多?
Expert Rev Clin Pharmacol. 2014 Nov;7(6):807-20. doi: 10.1586/17512433.2014.956090. Epub 2014 Sep 16.
8
Monitoring drug safety in Astrakhan, Russia.俄罗斯阿斯特拉罕地区的药物安全监测。
Int J Risk Saf Med. 2015;27 Suppl 1:S33-4. doi: 10.3233/JRS-150680.
9
Adverse drug reaction reporting: how can drug consumption information add to analyses using spontaneous reports?药品不良反应报告:药物消费信息如何为基于自发报告的分析提供补充?
Eur J Clin Pharmacol. 2018 Apr;74(4):497-504. doi: 10.1007/s00228-017-2396-y. Epub 2017 Dec 18.
10
An ABC of drug-related problems.药物相关问题入门
Drug Saf. 2000 Jun;22(6):415-23. doi: 10.2165/00002018-200022060-00001.

引用本文的文献

1
Detection of adverse drug events in e-prescribing and administrative health data: a validation study.电子处方和行政健康数据中不良药物事件的检测:一项验证研究。
BMC Health Serv Res. 2021 Apr 23;21(1):376. doi: 10.1186/s12913-021-06346-y.
2
Pharmacovigilance of suspected or confirmed therapeutic ineffectiveness of artemisinin-based combination therapy: extent, associated factors, challenges and solutions to reporting.基于青蒿素的联合疗法疑似或确认治疗无效的药物警戒:报告的程度、相关因素、挑战和解决方案。
Malar J. 2020 Nov 3;19(1):389. doi: 10.1186/s12936-020-03463-7.
3
Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase(®).

本文引用的文献

1
Drug-related hospital admissions.与药物相关的住院病例。
Pharmacotherapy. 1996 Jul-Aug;16(4):701-7.
2
Harmonisation in pharmacovigilance.药物警戒中的协调统一。
Drug Saf. 1994 Feb;10(2):93-102. doi: 10.2165/00002018-199410020-00001.
3
Drugs, money and society.毒品、金钱与社会。
最小化竞争偏倚后抗精神病药物与胃肠道先天性畸形的信号:使用Vigibase(®)数据进行的不成比例性分析
Drug Saf. 2016 Jul;39(7):689-96. doi: 10.1007/s40264-016-0413-1.
4
The development and evaluation of triage algorithms for early discovery of adverse drug interactions.用于早期发现药物不良相互作用的分诊算法的开发和评估。
Drug Saf. 2013 May;36(5):371-88. doi: 10.1007/s40264-013-0053-7.
5
Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.全球儿童疑似药物不良反应报告:使用 VigiBase 的探索性研究。
Drug Saf. 2011 May 1;34(5):415-28. doi: 10.2165/11587540-000000000-00000.
6
Reporting patterns indicative of adverse drug interactions: a systematic evaluation in VigiBase.提示药物不良反应相关性的报告模式:VigiBase 中的系统评价。
Drug Saf. 2011 Mar 1;34(3):253-66. doi: 10.2165/11586990-000000000-00000.
7
Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system.通过药物报告系统对患者使用抗抑郁药的体验进行评估。
Eur J Clin Pharmacol. 2007 Dec;63(12):1193-9. doi: 10.1007/s00228-007-0375-4. Epub 2007 Sep 15.
8
Therapeutic ineffectiveness: heads or tails?治疗无效:正面还是反面?
Drug Saf. 2002;25(7):485-7. doi: 10.2165/00002018-200225070-00002.
Br J Clin Pharmacol. 1995 Apr;39(4):343-5. doi: 10.1111/j.1365-2125.1995.tb04461.x.